FIGURE 4 3.5 Screening and validation of candidate DEGs and docking with drug molecules test The top 30 in GO and KEGG analyses provided some evidence for osteogenic differentiation and osteoblast proliferation
Patients taking semaglutide had significantly reduced levels of that marker
Moreover, the growing physician preference for treatments that offer both metabolic and cardiovascular benefits, growing emphasis on preventive cardiology, and expanding guidelines supporting the use of these therapies in high-risk cardiovascular patients are all factors driving segment growth
Recent FDA rulings, however, have forced Fella Health to prescribe only name-brand medications, like Wegovy and Zepbound, which are more expensive, but generally safer GLP-1 options
Severe gastroparesis (delayed stomach emptying) : since GLP-1 further slows gastric motility, this can worsen symptoms significantly